End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-22 pm EDT
5-day change
1st Jan Change
39.44
CNY
-2.38%
-3.14%
-33.08%
Acrobiosystems Co.,Ltd.'s Equity Buyback announced on July 18, 2023, has closed with 273,800 shares, representing 0.23% for CNY 16 million.
The company closed its plan on January 17, 2024.
Acrobiosystems Co.,Ltd. Proposes Final Cash Dividend for 2023
Apr. 23
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 18
CI
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research
Apr. 10
CI
Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.
Jan. 18
CI
Acrobiosystems Co.,Ltd.'s Equity Buyback announced on July 18, 2023, has closed with 273,800 shares, representing 0.23% for CNY 16 million.
Jan. 16
CI
Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.
Jan. 03
CI
Acrobiosystems Launches Gmp Grade Dll4 Protein to Accelerate Stem Cell Manufacturing
Nov. 16
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-29
CI
Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.
23-10-10
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-28
CI
Acrobiosystems Co.,Ltd. Approves Board Elections
23-08-03
CI
Acrobiosystems Co.,Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.
23-07-17
CI
Acrobiosystems Co.,Ltd. authorizes a Buyback Plan.
23-07-16
CI
ACROBiosystems, Through ACRO Certify and Under its Aneuro Brand, Announces Launch of in Vivo Electrophysiology Solutions for Neuroscience Research with Diagnostic Biochips
23-06-09
CI
Acrobiosystems Co.,Ltd. Approves the Cash Dividend for the Year 2022, Payment Date: 07 June 2023
23-05-31
CI
Acrobiosystems Co.,Ltd. Approves the Cash Dividend for the Year 2022
23-05-17
CI
Acrobiosystems Co.,Ltd. Proposes Final Cash Dividend for the Year 2022
23-04-26
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-24
CI
ACROBiosystems Launches New Logistics Center in Switzerland to Help Accelerate Drug Development Throughout Europe
22-11-18
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-24
CI
Certain A Shares of Acrobiosystems Co.,Ltd. are subject to a Lock-Up Agreement Ending on 19-OCT-2022.
22-10-18
CI
Shanghai Biaodu Biotech Co., Ltd. announced that it has received $3 million in funding from Baotou Hongyuan Investment Management Consultation Co., Ltd., Huaige Capital, Acrobiosystems Co.,Ltd.
22-09-22
CI
Acrobiosystems Co.,Ltd.(XSEC:301080) added to S&P Global BMI Index
22-09-19
CI
Acrobiosystems Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-28
CI
Acrobiosystems Co.,Ltd. Announces Cash Dividend, Payable on May 30, 2022
22-05-23
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Acrobiosystems Co Ltd is a China-based company specializing in providing recombinant protein and other key biological reagent products and technical services. The Company's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The Company's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.
More about the company
Last Close Price
39.44
CNY
Average target price
56.78
CNY
Spread / Average Target
+43.95%
Consensus
1st Jan change
Capi.
-33.08% 668M +38.69% 723B +34.28% 595B -4.49% 369B +20.24% 332B +2.12% 282B +17.02% 244B +9.31% 208B -5.07% 205B -0.35% 168B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1